ALLERGAN INC: Apotex Seeks Rehearing of ‘493 Patent Breach Suit

Subscribe
TOPICS: Commercial Services | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | North America | United States